Recent Advances of Ocular Drug Delivery Systems: Prominence of Ocular Implants for Chronic Eye Diseases

被引:12
|
作者
Mostafa, Mahmoud [1 ]
Al Fatease, Adel [2 ]
Alany, Raid G. [3 ,4 ]
Abdelkader, Hamdy [2 ]
机构
[1] Minia Univ, Fac Pharm, Dept Pharmaceut, Al Minya 61519, Egypt
[2] King Khalid Univ, Coll Pharm, Dept Pharmaceut, Abha 62223, Saudi Arabia
[3] Kingston Univ London, Sch Pharm, Kingston Upon Tames KT1 2EE, England
[4] Univ Auckland, Sch Pharm, Auckland 1010, New Zealand
关键词
chronic eye diseases; inserts; implants; ocular delivery; IN-VITRO CHARACTERIZATION; VIVO PHARMACODYNAMIC EVALUATION; NANOSTRUCTURED LIPID CARRIERS; DRY-EYE; SUSTAINED-RELEASE; EX-VIVO; MACULAR DEGENERATION; OPHTHALMIC DELIVERY; HYALURONIC-ACID; AQUEOUS-HUMOR;
D O I
10.3390/pharmaceutics15061746
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Chronic ocular diseases can seriously impact the eyes and could potentially result in blindness or serious vision loss. According to the most recent data from the WHO, there are more than 2 billion visually impaired people in the world. Therefore, it is pivotal to develop more sophisticated, long-acting drug delivery systems/devices to treat chronic eye conditions. This review covers several drug delivery nanocarriers that can control chronic eye disorders non-invasively. However, most of the developed nanocarriers are still in preclinical or clinical stages. Long-acting drug delivery systems, such as inserts and implants, constitute the majority of the clinically used methods for the treatment of chronic eye diseases due to their steady state release, persistent therapeutic activity, and ability to bypass most ocular barriers. However, implants are considered invasive drug delivery technologies, especially those that are nonbiodegradable. Furthermore, in vitro characterization approaches, although useful, are limited in mimicking or truly representing the in vivo environment. This review focuses on long-acting drug delivery systems (LADDS), particularly implantable drug delivery systems (IDDS), their formulation, methods of characterization, and clinical application for the treatment of eye diseases.
引用
收藏
页数:50
相关论文
共 50 条
  • [41] Ocular drug delivery systems:An overview
    Ashaben Patel
    Kishore Cholkar
    Vibhuti Agrahari
    Ashim K Mitra
    World Journal of Pharmacology, 2013, (02) : 47 - 64
  • [42] Polymeric microneedles for the eye: An overview of advances and ocular applications for minimally invasive drug delivery
    Mulkutkar, Madhura
    Damani, Mansi
    Sawarkar, Sujata
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 197
  • [43] Recent advances in novel formulation approaches for tacrolimus delivery in treatment of various ocular diseases
    Kailasam, Velmurugan
    Cheruvu, Sai Shreya
    Malani, Manisha
    Kameswari, Srujana Mosalikanti Sai
    Kesharwani, Prashant
    Nirmal, Jayabalan
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 78
  • [44] Recent advances in ceramic implants as drug delivery systems for biomedical applications
    Colilla, Montserrat
    Manzano, Miguel
    Vallet-Regi, Maria
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2008, 3 (04): : 403 - 414
  • [45] Nanoceria for ocular diseases: recent advances and future prospects
    Cui, W.
    Wang, Y.
    Luo, C.
    Xu, J.
    Wang, K.
    Han, H.
    Yao, K.
    MATERIALS TODAY NANO, 2022, 18
  • [46] Recent advances and prospects of nanoparticle-based drug delivery for diabetic ocular complications
    Wang, Siqi
    Yang, Hongyu
    Zheng, Jiaying
    Tong, Aiyang
    Mu, Sen
    Wang, Dongkai
    Zhao, Ming
    Li, Ji
    THERANOSTICS, 2025, 15 (08): : 3551 - 3570
  • [47] Formulation Advances in Posterior Segment Ocular Drug Delivery
    Sarkar, Tumpa
    Gogoi, Niva Rani
    Jana, Bani Kumar
    Mazumder, Bhaskar
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2025,
  • [48] Topical Advances in Mucoadhesive Ocular Drug Delivery System
    Billowria, Koushal
    Sandhu, Navjot Kaur
    Singh, Baljinder
    CURRENT DRUG DELIVERY, 2023, 20 (08) : 1127 - 1140
  • [49] Advances in ocular drug delivery: emphasis on the posterior segment
    Kang-Mieler, Jennifer J.
    Osswald, Christian R.
    Mieler, William F.
    EXPERT OPINION ON DRUG DELIVERY, 2014, 11 (10) : 1647 - 1660
  • [50] Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery
    Bhattacharjee, Arpita
    Das, Pranab J.
    Adhikari, Piya
    Marbaniang, Daphisha
    Pal, Paulami
    Ray, Subhabrata
    Mazumder, Bhaskar
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2019, 29 (01) : 113 - 126